rs3791878

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000663207.2(ERICH2-DT):​n.1143C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.233 in 152,114 control chromosomes in the GnomAD database, including 5,083 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 5083 hom., cov: 32)

Consequence

ERICH2-DT
ENST00000663207.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.405

Publications

30 publications found
Variant links:
Genes affected
ERICH2-DT (HGNC:55686): (ERICH2 divergent transcript)
GAD1 (HGNC:4092): (glutamate decarboxylase 1) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
GAD1 Gene-Disease associations (from GenCC):
  • early infantile epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 89
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAD1-AS1NR_197761.1 linkn.1448C>A non_coding_transcript_exon_variant Exon 4 of 4
GAD1-AS1NR_197762.1 linkn.1217C>A non_coding_transcript_exon_variant Exon 3 of 3
GAD1-AS1NR_197763.1 linkn.1274C>A non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERICH2-DTENST00000663207.2 linkn.1143C>A non_coding_transcript_exon_variant Exon 2 of 2
GAD1ENST00000454603.5 linkc.-64+2259G>T intron_variant Intron 1 of 3 4 ENSP00000402366.1 C9JLZ7
ERICH2-DTENST00000728834.1 linkn.358+1173C>A intron_variant Intron 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.233
AC:
35418
AN:
151996
Hom.:
5080
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0646
Gnomad AMI
AF:
0.293
Gnomad AMR
AF:
0.222
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.330
Gnomad FIN
AF:
0.326
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.313
Gnomad OTH
AF:
0.244
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.233
AC:
35423
AN:
152114
Hom.:
5083
Cov.:
32
AF XY:
0.234
AC XY:
17381
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0644
AC:
2676
AN:
41550
American (AMR)
AF:
0.222
AC:
3388
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
964
AN:
3466
East Asian (EAS)
AF:
0.228
AC:
1180
AN:
5168
South Asian (SAS)
AF:
0.332
AC:
1599
AN:
4820
European-Finnish (FIN)
AF:
0.326
AC:
3449
AN:
10586
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.313
AC:
21300
AN:
67952
Other (OTH)
AF:
0.245
AC:
516
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1303
2605
3908
5210
6513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.299
Hom.:
11025
Bravo
AF:
0.218
Asia WGS
AF:
0.280
AC:
972
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.4
DANN
Benign
0.65
PhyloP100
-0.41
PromoterAI
-0.00080
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3791878; hg19: chr2-171672191; API